Compare Expensify Inc (EXFY) vs Intuitive Surgical, Inc. (ISRG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Expensify Inc vs Intuitive Surgical, Inc. — how do they compare? Expensify Inc trades at $2.4 (market cap $208.82M), while Intuitive Surgical, Inc. trades at $424 (market cap $146.76B). The key difference: Intuitive Surgical, Inc. is far larger — about 702.8× Expensify Inc's market cap, and Expensify Inc is trading nearer its 52-week high, Intuitive Surgical, Inc. nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Expensify Inc for 41 Days and Intuitive Surgical, Inc. for 84 Days on average.
| EXFY | ISRG | |
|---|---|---|
Market Cap | $208.82M | $146.76B |
Volume | 456,102 | 2,529,814 |
Sector | Technology | Health |
52-Week High | $2.72 | $592.85 |
52-Week Low | $0.75 | $332.02 |
Typical Hold Time | 41 Days | 84 Days |
Enterprise Value | $148.44M | $141.54B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Expensify (EXFY) trades at $2.40, up 5.73% today, showing technical bullish momentum. The company reported mixed quarterly results with recent beats but remains unprofitable with negative margins. Recent business developments include strategic AI integrations and European expansion of its corporate card program, signaling growth initiatives. Analyst sentiment is cautiously optimistic with a 50% buy rating and $13.75 consensus target, though fundamentals show continued losses.
The outlook remains speculative given persistent negative profitability despite revenue stabilization. Investment opportunity hinges on successful execution of AI integrations and international expansion driving future profitability. Key risks include competitive pressure in expense management software and the challenge of achieving sustainable positive earnings amid ongoing operational losses.
Intuitive Surgical (ISRG) trades at $423.96, up 2.28% with strong bullish momentum. The stock shows robust fundamentals with 2025 revenue reaching $10.06B and net income of $2.86B, maintaining 28.45% net margins. Recent quarters consistently beat EPS estimates, while technical indicators signal bullish moving averages. Analyst consensus remains strongly positive with 70% buy ratings and $480.78 price target, representing 13% upside potential.
ISRG's leadership in robotic surgery and expanding international presence in India and Japan provide growth catalysts, though China weakness and competitive pressures present risks. The stock's premium valuation (P/E 47.64) reflects high growth expectations, requiring continued execution. Current levels near resistance at $427 may test near-term momentum ahead of Q3 earnings.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Expensify Inc
Expensify Inc is a cloud-based expense management software platform that helps the smallest to the largest businesses simplify the way they manage money. More than 10 million people use Expensify's free features, which include corporate cards, expense tracking, next-day reimbursement, invoicing, bill pay, and travel booking in one app.
Read more on EXFY →About Intuitive Surgical, Inc.
Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed nearly 7,000 da Vinci systems in hospitals worldwide, with more than 4,000 installations in the United States and a growing number in emerging markets.
Read more on ISRG →
